Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study
Article in PLOS ONE (February 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in PLOS ONE (February 2023)
Article in Infectious Diseases and Therapy (March 2021)
Article in Healthcare (May 2020)